Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases
Ann‐Katrin Sommer(Ludwig-Maximilians-Universität München), Andreas Roidl(Ludwig-Maximilians-Universität München)
Cited by 18
Related Papers
Downregulation of GRK5 hampers the migration of breast cancer cells
|Scientific Reports|2019|22
Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells
|Translational Oncology|2014|11
Development of chemoresistance and formation of metastases: New aspects of two major obstacles in breast cancer treatment
|Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)|2021|1